Memorial Sloan Kettering Adopts MIM Software Radiation Therapy Solution

first_img News | Radiation Therapy | August 15, 2019 First Patient Enrolled in World’s Largest Brain Cancer Clinical Trial Henry Ford Cancer Institute is first-in-the-world to enroll a glioblastoma patient in the GBM AGILE Trial (Adaptive… read more March 4, 2016 — MIM Software Inc. has recently collaborated with Memorial Sloan Kettering Cancer Center (MSK), nationally recognized by the National Cancer Institute and ranked by U.S. News & World Report as one of the top hospitals for cancer care in the country.MSK will be using MIM Software’s radiation oncology solution as a software source for handling dose accumulation, contour creation, image fusions and deformable registrations, as well as a host of other clinical and research work. The software will be deployed at the main campus in Manhattan, along with all outpatient facilities that extend from Manhattan through the New York suburbs as well as New Jersey and Long Island.”In the ever increasing world of complex treatments for cancer, we are always looking to enhance our clinical workflow and advance the research we do,” said Sandra Fontenla, senior physicist-clinical coordinator for external beam at MSK.”Radiation therapy has become increasingly reliant on imaging for the safe and accurate treatment of cancer,” Fontenla continues. “Our goal is to accomplish faster and more precise image registrations to enable physicians to identify tumors more quickly and accurately.”For more information: www.mimsoftware.com FacebookTwitterLinkedInPrint分享 Feature | August 05, 2019 | Dave Fornell, Editor Most Popular Radiology and Radiotherapy Topics in July 2019 August 5, 2019 — Here is the list of the most popular content on the Imaging Technology New (ITN) magazine website fr read more Related Content News | Radiation Therapy | August 16, 2019 Drug Accelerates Blood System’s Recovery After Radiation, Chemotherapy A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem… read more The MD Anderson Proton Therapy Center expansion is expected to be completed in 2023. Rendering courtesy of Stantec. Catalyst PT image courtesy of C-RAD News | Patient Positioning Radiation Therapy | August 15, 2019 Mevion and C-RAD Release Integration for Improved Proton Therapy Treatment Quality Mevion Medical Systems and C-RAD announced the integration between the C-RAD Catalyst PT and the Mevion S250i proton… read more The top piece of content in July was a video interview explaining how Princess Margaret Cancer Center is using machine learning to create automated treatment plans. This was a hot topic at the American Association of Physicists in Medicine (AAPM) 2019 meeting in July.  News | Proton Therapy | August 08, 2019 MD Anderson to Expand Proton Therapy Center The University of Texas MD Anderson Cancer Center unveiled plans to expand its Proton Therapy Center during a… read more News | Radiation Therapy | August 02, 2019 Varian Showcases Cancer Care Systems and Software at AAPM 2019 Varian showcased systems and software from its cancer care portfolio, including the Identify Guidance System, at the… read more News | Patient Positioning Radiation Therapy | August 07, 2019 Qfix kVue One Proton Couch Top Validated by Mevion Medical Systems Qfix and Mevion Medical Systems announced that a special version of the kVue One Proton couch top is now both validated… read more News | Radiation Therapy | March 04, 2016 Memorial Sloan Kettering Adopts MIM Software Radiation Therapy Solution Software will be used to handle dose accumulation, contour creation, image fusion and other clinical and research work News | Proton Therapy | August 06, 2019 IBA Signs Contract to Install Proton Therapy Center in Kansas IBA (Ion Beam Applications S.A.) recently signed a contract and received the first payment for a Proteus One solution… read more News | Brachytherapy Systems | August 14, 2019 Efficacy of Isoray’s Cesium Blu Showcased in Recent Studies August 14, 2019 — Isoray announced a trio of studies recently reported at scientific meetings and published in medica read more News | Radiation Oncology | July 31, 2019 Laura Dawson, M.D., FASTRO, Chosen as ASTRO President-elect The members of the American Society for Radiation Oncology (ASTRO) elected four new officers to ASTRO’s Board of… read more Following radiation, the bone marrow shows nearly complete loss of blood cells in mice (left). Mice treated with the PTP-sigma inhibitor displayed rapid recovery of blood cells (purple, right). Credit: UCLA Broad Stem Cell Research Center/Nature Communicationslast_img

Leave a Reply

Your email address will not be published. Required fields are marked *